Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Clinical trial NCT05397639 · RECRUITING
Trial details
- NCT number
- NCT05397639
- Sponsor
- Suven Life Sciences Limited
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2026-12-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.